AEZS Aeterna Zentaris Inc.

-0.01  -0%
Previous Close 2.69
Open 2.69
Price To Book -12.18
Market Cap 43,443,516
Shares 16,210,267
Volume 71,045
Short Ratio
Av. Daily Volume 174,253

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued November 2014. Approval announced following resubmission December 20, 2017.
Macimorelin Acetate - Macrilen
Adult Growth Deficiency
Phase 3 trial did not meet primary endpoint - May 1, 2017.
Endometrial cancer

Latest News

  1. Aeterna Zentaris Provides Corporate Update
  2. Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting
  3. Aeterna Zentaris (AEZS) Reports Q1 Loss, Misses Revenue Estimates
  4. Aeterna Zentaris: 1Q Earnings Snapshot
  5. Aeterna Zentaris Reports First Quarter 2019 Financial and Operating Results
  6. What's in the Cards for AEterna (AEZS) This Earnings Season?
  7. Analysts Estimate Aeterna Zentaris (AEZS) to Report a Decline in Earnings: What to Look Out for
  8. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results
  9. Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019
  10. Aeterna Zentaris (AEZS) Moves to Buy: Rationale Behind the Upgrade
  11. The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie
  12. Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor
  13. What's in the Cards for Aeterna (AEZS) This Earnings Season?
  14. The Zacks Analyst Blog Highlights: Celgene, Charles River Laboratories International, Catalent and Aeterna Zentaris
  15. 4 Drug Stocks to Buy Despite Price Hearing Woes
  16. The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna
  17. 5 Tiny Biotech Stocks With Superb Growth Potential
  18. Is AEterna Zentaris (AEZS) Outperforming Other Medical Stocks This Year?
  19. Implied Volatility Surging for Aeterna Zentaris (AEZS) Stock Options